REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 175 filers reported holding REPLIGEN CORP in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,943,320 | +15.5% | 326,667 | +2.7% | 0.02% | +15.4% |
Q2 2023 | $44,984,280 | -14.4% | 318,000 | +1.8% | 0.01% | -18.8% |
Q1 2023 | $52,571,757 | +1.1% | 312,258 | +1.6% | 0.02% | -5.9% |
Q4 2022 | $52,021,852 | -5.7% | 307,258 | +4.2% | 0.02% | -15.0% |
Q3 2022 | $55,178,000 | +15.6% | 294,893 | +0.4% | 0.02% | +17.6% |
Q2 2022 | $47,724,000 | -12.0% | 293,863 | +2.0% | 0.02% | +6.2% |
Q1 2022 | $54,205,000 | -27.2% | 288,185 | +2.5% | 0.02% | -27.3% |
Q4 2021 | $74,471,000 | -5.9% | 281,193 | +2.7% | 0.02% | -15.4% |
Q3 2021 | $79,118,000 | +3.3% | 273,772 | -28.7% | 0.03% | +4.0% |
Q2 2021 | $76,599,000 | +5.2% | 383,721 | +2.5% | 0.02% | -7.4% |
Q1 2021 | $72,803,000 | -1.6% | 374,477 | -3.0% | 0.03% | -6.9% |
Q4 2020 | $73,974,000 | +29.1% | 386,021 | -0.6% | 0.03% | +11.5% |
Q3 2020 | $57,297,000 | +23.4% | 388,343 | +3.4% | 0.03% | +13.0% |
Q2 2020 | $46,418,000 | +4.3% | 375,513 | -18.5% | 0.02% | -11.5% |
Q1 2020 | $44,496,000 | +9.3% | 460,905 | +4.7% | 0.03% | +18.2% |
Q4 2019 | $40,723,000 | +22.7% | 440,241 | +1.8% | 0.02% | +10.0% |
Q3 2019 | $33,176,000 | +29.4% | 432,596 | +45.1% | 0.02% | +25.0% |
Q2 2019 | $25,632,000 | +42.7% | 298,213 | -1.9% | 0.02% | +33.3% |
Q1 2019 | $17,967,000 | +27.8% | 304,103 | +14.0% | 0.01% | +9.1% |
Q4 2018 | $14,063,000 | +18.5% | 266,645 | +24.6% | 0.01% | +37.5% |
Q3 2018 | $11,870,000 | +24.8% | 214,019 | +5.8% | 0.01% | +14.3% |
Q2 2018 | $9,512,000 | +38.1% | 202,201 | +6.2% | 0.01% | +40.0% |
Q1 2018 | $6,890,000 | -9.6% | 190,417 | -9.3% | 0.01% | -16.7% |
Q4 2017 | $7,619,000 | -11.4% | 210,000 | -6.4% | 0.01% | -25.0% |
Q3 2017 | $8,599,000 | -3.7% | 224,388 | +4.1% | 0.01% | 0.0% |
Q2 2017 | $8,929,000 | +7.4% | 215,450 | -8.8% | 0.01% | 0.0% |
Q1 2017 | $8,315,000 | -3.2% | 236,201 | -15.3% | 0.01% | -11.1% |
Q4 2016 | $8,593,000 | +6.3% | 278,812 | +4.2% | 0.01% | -10.0% |
Q3 2016 | $8,082,000 | +68.2% | 267,673 | +52.4% | 0.01% | +66.7% |
Q2 2016 | $4,805,000 | +6.0% | 175,590 | +3.9% | 0.01% | 0.0% |
Q1 2016 | $4,535,000 | -2.1% | 169,080 | +3.3% | 0.01% | 0.0% |
Q4 2015 | $4,630,000 | +12.0% | 163,654 | +10.3% | 0.01% | 0.0% |
Q3 2015 | $4,133,000 | +14.9% | 148,394 | +70.3% | 0.01% | +20.0% |
Q2 2015 | $3,597,000 | -52.2% | 87,154 | -64.9% | 0.01% | -54.5% |
Q1 2015 | $7,530,000 | +17.2% | 247,998 | -23.5% | 0.01% | +10.0% |
Q4 2014 | $6,423,000 | -1.8% | 324,351 | -1.3% | 0.01% | -9.1% |
Q3 2014 | $6,544,000 | +35.7% | 328,649 | +55.4% | 0.01% | +37.5% |
Q2 2014 | $4,821,000 | +102.2% | 211,540 | +14.1% | 0.01% | +100.0% |
Q1 2014 | $2,384,000 | +103.4% | 185,380 | +115.8% | 0.00% | +100.0% |
Q4 2013 | $1,172,000 | +20.3% | 85,900 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $974,000 | +34.9% | 85,900 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $722,000 | – | 85,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |